Almost everyone can say that they have been impacted by cancer in some way, whether themselves, a loved one, co-worker, etc. But, there is a type of blood cancer that affects thousands of people in the United States every year, most commonly in early adulthood that isn’t discussed often, due in part to its rarity and because until recently, treatment for newly diagnosed patients hadn’t changed in more than 40 years.
Hodgkin lymphoma (HL) is a cancer that starts in white blood cells called lymphocytes, which are part of the body’s immune system.
The Lymphoma Coalition states that over 62,000 people worldwide are diagnosed with HL each year Approximately 8,500 people will be diagnosed with HL during 2018 and about 1,050 of them will die from the disease. Up to 30 percent of advanced-stage HL patients will see their disease worsen after initial treatment
